Accretion Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Sanand, Gujarat, India, established in 2023.
2023 Sanand, Gujarat, India Active
Last Updated:
Access Report
About Accretion Pharmaceuticals Limited

Accretion Pharmaceuticals Limited, a active public limited company, was established on 29 November 2023 in Sanand, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U21004GJ2023PLC146545. Registered under ROC Roc Ahmedabad. it is listed. It has an authorized capital of ₹13.00 Cr and a paid-up capital of ₹11.12 Cr.

In 2024, it reported revenue of ₹13.41 Cr and a net worth of ₹5.49 Cr. Its leadership includes Hardik Mukundbhai Prajapati (Director), Harshad Nanubhai Rathod (Director), Mayur Popatlal Sojitra (Director). Past directors included Vijay Bharatbhai Anadkat, Mayur Popatlal Sojitra, Vivek Ashok Kumar Patel. It holds ₹10.73 Cr open charges and no settled loans. Its latest AGM occurred on 25 September 2025, with the balance sheet filed on 31 March 2025. It is based at 29 Xcelon Ind Park 1, B/H, Intas Pharmaceuticals, Sanand, Gujarat, 382213.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L21004GJ2023PLC146545

  • Registration Number

    146545

  • Incorporation Date

    29 November 2023

  • Authorized Capital

    ₹13.00 Cr

  • Paid-Up Capital

    ₹11.12 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Listed

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 13.00 Cr
  • Paid Up Capital ₹ 11.12 Cr
  • Company Age 2 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 10.73 Cr
Company report

Accretion Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Accretion Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Accretion Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Hardik Mukundbhai Prajapati Director 29 Nov 2023 Current
Harshad Nanubhai Rathod Director 29 Nov 2023 Current
Mayur Popatlal Sojitra Director 29 Nov 2023 Current
Vivek Ashok Kumar Patel Managing Director 29 Nov 2023 Current
Chand Rameshbhai Kanabar Director 19 Apr 2025 Current
Grishma A Shewale Director 09 Jul 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 12 Jul 2024 Past
Pramod Abcsdd Director 24 Sep 2025 Past
Pramod Abcsdd Director 08 Jul 2024 Past
Pramod Abcsdd Additional Director 24 Sep 2025 Past
Pramod Abcsdd Additional Director 12 Jul 2024 Past
Pramod Abcsdd Additional Director 12 Jul 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Accretion Pharmaceuticals.

Accretion Pharmaceuticals Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Accretion Pharmaceuticals revenue growth over time
Accretion Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Accretion Pharmaceuticals?

In 2024, Accretion Pharmaceuticals had a promoter holding of 96.00% and a public holding of 4.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹107,300,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Indian Bank : 10.73 Cr
Latest Charge Details
Date Lender Amount Status
05 Jan 2024 Indian Bank ₹10.73 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Accretion Pharmaceuticals?

Accretion Pharmaceuticals has a workforce of 0 employees as of Oct 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Accretion Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accretion Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Accretion Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Accretion Pharmaceuticals Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records. was completed.

  • Director Appointment

    The activity Nishtha Harivanshi Pamnani was appointed as a Director was appointed as a Director on 10 Jun 2025 & has been associated with this company since 8 months 24 days . was completed.

  • Director Appointment

    Chand Rameshbhai Kanabar was appointed as a Director was appointed as a Director on 19 Apr 2025 & has been associated with this company since 10 months 15 days . was recorded as a recent event.

  • Balance Sheet

    Progress on Accretion Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.

  • Charges

    Progress on A charge with Indian Bank of Rs. 10.73 Cr registered on 05 Jan 2024 with Charge ID 100844260 was modified on 13 Dec 2024. was documented.

  • Director Appointment

    The activity Harshad Nanubhai Rathod was appointed as a Cfo was appointed as a Cfo on 26 Jul 2024 & has been associated with this company since 1 year 7 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Accretion Pharmaceuticals Limited?

The CIN of Accretion Pharmaceuticals Limited is L21004GJ2023PLC146545.

Where is Accretion Pharmaceuticals Limited headquartered?

Accretion Pharmaceuticals Limited is headquartered at 29 Xcelon Ind Park 1, B/H, Intas Pharmaceuticals, Sanand, Gujarat, 382213.

When was Accretion Pharmaceuticals Limited incorporated?

Accretion Pharmaceuticals Limited was incorporated on 29 November 2023.

Who are the current directors of Accretion Pharmaceuticals Limited?

The current directors of Accretion Pharmaceuticals Limited are

What is the primary industry of Accretion Pharmaceuticals Limited?

The primary industry of Accretion Pharmaceuticals Limited is Manufacturing.

Is Accretion Pharmaceuticals Limited a listed company?

Accretion Pharmaceuticals Limited is listed.

What is the capital structure of Accretion Pharmaceuticals Limited?

The authorized capital of Accretion Pharmaceuticals Limited is ₹13.00 Cr, and the paid-up capital is ₹11.12 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available